FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.73 CNY | -3.08% |
|
-3.91% | -38.63% |
| Sales 2022 | 386M 53.25M | Sales 2023 | 423M 58.35M | Capitalization | 4.08B 563M |
|---|---|---|---|---|---|
| Net income 2022 | -127M -17.53M | Net income 2023 | -349M -48.17M | EV / Sales 2022 | 16.4 x |
| Net Debt 2022 | 72.57M 10.02M | Net Debt 2023 | 256M 35.4M | EV / Sales 2023 | 10.3 x |
| P/E ratio 2022 |
-48.9
x | P/E ratio 2023 |
-11.7
x | Employees | 908 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.74% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.08% | ||
| 1 week | -3.91% | ||
| Current month | -16.73% | ||
| 1 month | -20.60% | ||
| 3 months | -26.50% | ||
| 6 months | -36.11% | ||
| Current year | -38.63% |
1 week
15.09
17.06
1 month
14.7219.80
Current year
14.7226.74
1 year
14.7233.77
3 years
14.7265.20
5 years
14.7265.20
10 years
12.88167.52
| Managers | Title | Age | Since |
|---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 01-06-27 |
Jian Hui Guan
DFI | Director of Finance/CFO | 48 | 17-07-24 |
Yuan Li Li
CHM | Chairman | 66 | 10-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 01-06-27 |
Li Qing Ye
BRD | Director/Board Member | 54 | 11-09-19 |
Guo Dong Li
BRD | Director/Board Member | 53 | 01-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 15.73 | -3.08% | 3,384,565 |
| 24-04-19 | 16.23 | +3.71% | 2,165,190 |
| 24-04-18 | 15.65 | -1.70% | 1,738,200 |
| 24-04-17 | 15.92 | +7.28% | 2,787,200 |
| 24-04-16 | 14.84 | -9.35% | 3,032,200 |
End-of-day quote Shenzhen S.E., April 21, 2024
More quotes
Fujian Cosunter Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of nucleoside anti-HBV drugs. The Company's major products include Adefovir Dipivoxil Tablets, Lamivudine Tablets, Entecavir Capsules and other nucleoside anti-HBV drugs. The Company also produces over-the-counter (OTC) drugs, such as ferrous fumarate and ganoderma capsules.
Sector
Pharmaceuticals
Calendar
2024-04-24
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.63% | 357M | |
| +25.46% | 654B | |
| +25.38% | 552B | |
| -4.86% | 356B | |
| +16.44% | 319B | |
| +8.34% | 295B | |
| +6.13% | 211B | |
| +2.93% | 206B | |
| -7.65% | 197B | |
| -8.79% | 147B |
- Stock Market
- Equities
- 300436 Stock
